Skip to main content

Cookies

This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to the Privacy Policy and Terms of Use. Please read our cookie policy for more information on the use of cookies on this website.

Top
  • COVID-19
    • COVID-19 Resources
  • Solutions
    • By Market
      • Academic Research
      • Agriculture
      • Biobanking
      • Government
      • Pharma and Biotech
      • Research Foundations
    • By Application
      • Clinical Trial Sample Management
      • Discovery, Compound Management and Biologics
      • Molecular Diagnostic Solutions
      • Regenerative Medicine and Cell Therapy
      • Sample Preparation and Lab Services
      • Sample Transport and Cold-Chain Logistics
      • Vaccine Development
    • Geography
      • Asia-Pacific
      • Europe
      • North America
  • Products
    • Azenta Life Sciences Virtual Booth
    • Automated Sample Storage Systems
      • Cold Storage (Ambient to -20°C)
      • Ultra Cold Storage (ULT -80°C)
      • Cryogenic Storage (-190°C)
    • Consumables & Instruments
      • Sample Tube Solutions
      • PCR & Microplate Solutions
      • Sample Cooling & Heating Labware
    • Informatics Platforms & LIMS/LIS
    • Integrations
    • Sterilization Services
    • Microplate Coding Services
  • Services
    • Genomics Services by GENEWIZ
    • Sample and Material Management Solutions
    • Sample and Material Storage
    • Clinical Trial Management
    • Drug Products Storage and Distribution
    • Sample Sourcing
    • Sample Prep and Lab Services
    • Lab Moving and Biological Transport
    • Business Continuity and Risk Mitigation
  • Support
    • Technical Support
    • Product Support Plans
    • Product Updates
    • Sample Tube Pack Request
    • Plate & Seal Sample Request
  • Resources
  • Blog
  • About Us
    • Events
    • About Azenta Life Sciences
    • Management Team
    • Board of Directors
    • Global Locations
    • Investor Relations
    • News
    • Careers
    • Quality
    • Certifications
  • Contact Us

Utility Navigation

  • Life Sciences Customer Login
  • GENEWIZ
  • BioInventory Login
  • Portals Login
  • Portals
  • Careers
Home

Utility Navigation

  • Life Sciences Customer Login
  • GENEWIZ
  • BioInventory Login
  • Portals Login
  • Portals
  • Careers

Main Navigation

  • COVID-19
    Vaccine Development
    Vaccine Development

    Accelerating global operations to manage and process samples critical to vaccine development.

    Azenta Life Sciences Virtual Booth
    Azenta Life Sciences Virtual Booth

    The exhibition experience to your desktop or mobile device

    • COVID-19 Resources
  • Solutions
    • By Market
      • Academic Research
      • Agriculture
      • Biobanking
      • Government
      • Pharma and Biotech
      • Research Foundations
    • By Application
      • Clinical Trial Sample Management
      • Discovery, Compound Management and Biologics
      • Molecular Diagnostic Solutions
      • Regenerative Medicine and Cell Therapy
      • Sample Preparation and Lab Services
      • Sample Transport and Cold-Chain Logistics
      • Vaccine Development
    • Geography
      • Asia-Pacific
      • Europe
      • North America
    Resources Center

    Learn about sample management best practices, gain advice from industry leaders, gain access to global regulatory and logistics guidelines and find simple support tools that can help you make better sample management decisions.

    Resources Center
  • Products
    Azenta Sample Pack and Catalog
    Sample Tube Pack Request

    Improve sample tracking, ensure sample integrity and drive process efficiency with Azenta Sample Storage Tubes. Explore the range, and select the best tube for your workflow.

    Low DNA Binding Microplates
    Low Binding Microplates

    Ultra low DNA binding microplates made from PP, fit for Next Generation Sequencing (NGS) and other sensitive applications with ultra-low DNA input. Off the shelf options. Custom solutions on request.

    • Azenta Life Sciences Virtual Booth
    • Automated Sample Storage Systems
      • Cold Storage (Ambient to -20°C)
      • Ultra Cold Storage (ULT -80°C)
      • Cryogenic Storage (-190°C)
    • Consumables & Instruments
      • Sample Tube Solutions
      • PCR & Microplate Solutions
      • Sample Cooling & Heating Labware
    • Informatics Platforms & LIMS/LIS
    • Integrations
    • Sterilization Services
    • Microplate Coding Services
  • Services
    Clinical Trial Management
    Clinical Trial Management

    Life science organizations must collect and manage large numbers of research samples to bring a new therapeutic or diagnostic to market. This is a complex process.

    Sample Preparation & Lab Analytical Services
    Genomics Services by GENEWIZ

    Comprehensive genomics services provide end to end solutions and best-in-class data quality from the trusted experts in genomics.

    • Genomics Services by GENEWIZ
    • Sample and Material Management Solutions
    • Sample and Material Storage
    • Clinical Trial Management
    • Drug Products Storage and Distribution
    • Sample Sourcing
    • Sample Prep and Lab Services
    • Lab Moving and Biological Transport
    • Business Continuity and Risk Mitigation
  • Support
    disaster recovery
    How Safe Are Your Samples?

    Plastic storage tubes are used in laboratories worldwide to store biological and chemical samples.

    Product Support Plans
    Product Support Plans

    Azenta  Life Sciences' world class service team is committed to ensuring you meet your business objectives by providing a flexible portfolio of service products designed to optimize up-time and productivity.

    • Technical Support
    • Product Support Plans
    • Product Updates
    • Sample Tube Pack Request
    • Plate & Seal Sample Request
  • Resources
  • Blog
  • About Us
    Putting a Sample Kit in an envelope
    Quality Assurance Certifications

    Azenta Life Sciences has established, documented, implemented and currently maintains a quality management system that fulfills the needs of customers.

    About Azenta Life Sciences
    About Azenta Life Sciences

    We are Azenta Life Sciences. We provide unrivaled sample exploration and management solutions to help our customers accelerate discovery, development and delivery.

    • Events
    • About Azenta Life Sciences
    • Management Team
    • Board of Directors
    • Global Locations
    • Investor Relations
    • News
    • Careers
    • Quality
    • Certifications
  • Contact Us

Blog

You are here

  • Home
  • Blog
  • Biobanking 3.0 – How North America Tackles Biorepository Certification

Biobanking 3.0 – How North America Tackles Biorepository Certification

By Katheryn Shea March 14, 2018

inside of BioStore -80°C Automated Sample Storage System

 

Modern biomedical research relies on a large variety of high quality biospecimens, annotated with precise and detailed metadata. Consequently, biorepositories must secure, and convey to their customers, excellence in all of their operations. Enter two biobanking accreditation and certification programs that include external review.

Garbage in, garbage out. In all scientific research, this is the number one mantra delivered to students by capable instructors. For good reason. No experiment can produce data that would allow meaningful conclusions if the material used in the test was flawed in ways unknown to the scientist. It is therefore not surprising that customers of biobanking facilities are very concerned with, and sometimes skeptical about, the quality of the procured samples.

This poses a challenge for biorepositories. In addition to ensuring efficiency of their operations they also have to earn their customer’s trust. How can they instill confidence to customers that the facility’s operations are failsafe and top notch? Accreditations or certificates that require evidence of proper training programs, confirm adherence to best biobanking practice and include reliable documentation would be a good start. Luckily, these now exist. A recent review by leading scientists in the biobanking field examines the separate approaches taken by the Canadian Tissue Repository Network (CTRNet) and the College of American Pathologists (CAP) to secure and authenticate the quality of the operations of biobanking facilities. 1

The two programs have a different approach to certification requirements, but share one key element – the assessment of biobanking operations by an external review. Such an external review is the hallmark of the latest generation of biorepositories on an evolutionary path that started in the 1980s with the advent of molecular biology in health research. These early, first generation, biobanking facilities underwent a qualitative leap into a second generation when the –omics era revolutionized medical research in the early 2000s. Now, however, as research moves on to go more and more global, a new focus has emerged – that of standardization between different biobanking facilities, requiring external oversight – and biobanking 3.0 was born. 2

So how do these two different certification programs work? The CTRNet Biobank Certification Program is basically built on four cornerstones. First, information about the biobank is submitted to a registry, which allows classification and determination of education and documentation requirements through a standardized, refined decision tool 3 that considers scale, user type, data format and leadership of the biorepository. Second, a comprehensive biobanking education course is completed that ensures proper training of biorepository personnel. Third, self-assessment is required against the CTRNet best practice guidelines to identify any problematic areas in biobanking operations. Fourth and final, an external peer assessment is performed to guarantee compliance with required best practice operational procedures. The first two cornerstones (the registration component of the program) were launched in 2011, and the final two (the certification component) went live in 2013. To date, over 100 biorepositories have participated in the program, about one third of which are located outside of Canada.

The US-based CAP Biorepository Accreditation Program is based on standards, which are evaluated by a set of checklist requirements that is continually developed and modified by biorepository experts and specialists from CAP’s other accreditation programs. Guidelines and best practices of multiple relevant societies and institutes such as ISBER (International Society for Biological and Environmental Repositories) 4 or the Biorepositories and Biospecimen Research Branch of the National Cancer Institute 5 are incorporated into the checklist, and new versions of the requirements are issued annually by the Biorepository Accreditation Committee. Since biorepositories are very diverse, the program has a very broad scope and biobanking facilities apply for accreditation based on the character of their activities, with specific requirements tailored for specific activities. Checklist requirements are classified according to their impact into phase I (no direct impact on health and safety of patients, clients or personnel) and phase II (direct impact). Importantly, the program incorporates external peer evaluation by inspectors that work in the same field and are formally trained by CAP. The accreditation program is on a 3-year cycle with an external inspection in year 1 and subsequent annual self-assessment and CAP-led discussion of the findings. Launched in 2012, there are currently 42 US-based biorepositories that are fully CAP BAP accredited, and 13 more are actively pursuing accreditation. Here at Azenta Life Sciences, we are proud to have been CAP-BAP accredited since January 2013.

Undoubtedly, these programs are huge steps into the right direction, but given the increasingly global character of modern research, international standards are highly desirable. Luckily, there is an organization that develops such standards – the International Organization for Standardization (ISO). Several of the standards crafted by this organization can be, and already are, applied to the biobanking field. An example is ISO 9001:2015 (Quality Management Systems – Requirements) - based on this standard, Azenta Life Sciences recently obtained a National Quality Assurance (NQA) Global Assurance Certificate for the US and the UK. In addition to this and similar ISO standards, increasingly desirable and eagerly awaited unified international biorepository-specific guidelines are currently being developed. 6

Meanwhile, biobanking facilities in North America (and elsewhere) have the option to get certified according to one of the two programs outlined above. Such accreditation will establish a higher level of trust with customers, and improve the quality of the biorepository operational procedures. Given the big diversity of biobanking functions, it is challenging to craft a precise framework of international standards that cover all these operations, but necessity usually sparks ingenuity, and we here at Azenta Life Sciences support and welcome these efforts wholeheartedly.

 

References

1. Barnes RO, et al. The Canadian Tissue Repository Network Biobank Certification and the College of American Pathologists Biorepository Accreditation Programs: Two Strategies for Knowledge Dissemination in Biobanking. Biopreserv Biobank. 2017; 15(1): 9-16.

2. Simeon-Dubach D & Watson P. Biobanking 3.0: Evidence based and customer focused biobanking. Clin Biochem 2014; 47:300–308.

3. Watson PH & Barnes RO. A proposed schema for classifying human research biobanks. Biopreserv Biobank 2011; 9:327–333.

4. International Society for Biological and Environmental Repositories. Best practices for repositories—Collection, storage, retrieval, and distribution of biological materials for research, third edition. Biopreserv Biobank 2012; 10: 81–160.

5. NCI Best Practices for Biospecimen Resources. Washington, DC: Biorepositories and Biospecimen Research Branch, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services; 2016. https://biospecimens.cancer.gov/bestpractices/2016-NCIBestPractices.pdf

6. Furuta K & Schacter B. Report on status of ISO276/WG2 on biobanks and bioresources: International standards for biobanking. Biopreserv Biobank 2015; 13:452–453.

 

Katheryn Shea

Katheryn Shea

Katheryn Shea is Global Biobanking Lead at Azenta Life Sciences. Mrs. Shea is an accomplished biobanking expert with 20+ years of industry experience. Former President of ISBER, Mrs. Shea has authored numerous peer-reviewed publications and remains an active member of the College of American Pathologists Biorepositories Accreditation Program.

  • Biobanking
  • Sample Storage
  • Preclinical & Clinical
Home
Facebook twitter youtube linkedin
Copyright © 2023 Azenta US, Inc.

Footer menu

  • Privacy Policy
  • Cookie Policy
  • Terms and Conditions
  • Terms of Use
  • Careers
  • Subscribe